Does oxytocin lead to emotional interference during a working memory paradigm?

Por Tollenaar, Marieke S., Ruissen, M., Elzinga, B. M., de Bruijn, E. R. A.
Publicado no Psychopharmacology (Berl) (2017)

Mistakes that affect others: An fMRI study on processing of own errors in a social context

Por Radke, Sina, de Lange, F. P., Ullsperger, M., de Bruijn, E. R. A.
Publicado em 2011

Pharmacokinetics and tolerance of intravenous and intramuscular phylloquinone(vitamin K(1)) mixed micelles formulation

Por SOEDIRMAN, J. R., DE BRUIJN, E. A., MAES, R. A. A., HANCK, A., GRÜTER, J.
Publicado em 1996

EEG correlates of impaired self-other integration during joint-task performance in schizophrenia

Por de la Asuncion, J., Bervoets, C., Morrens, M., Sabbe, B., De Bruijn, E. R. A.
Publicado no Soc Cogn Affect Neurosci (2015)

Non-invasive (19)F MR spectroscopy of 5-fluorocytosine to 5-fluorouracil conversion by recombinant Salmonella in tumours

Por Dresselaers, T, Theys, J, Nuyts, S, Wouters, B, de Bruijn, E, Anné, J, Lambin, P, Van Hecke, P, Landuyt, W
Publicado em 2003

Variations in exposure to mitomycin C in an in vitro colony-forming assay.

Por Slee, P. H., de Bruijn, E. A., Leeflang, P., Kuppen, P. J., van den Berg, L., van Oosterom, A. T.
Publicado em 1986

Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.

Por Peters, G. J., Braakhuis, B. J., de Bruijn, E. A., Laurensse, E. J., van Walsum, M., Pinedo, H. M.
Publicado em 1989

Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11

Por Wildiers, H, Guetens, G, De Boeck, G, Verbeken, E, Landuyt, B, Landuyt, W, de Bruijn, E A, van Oosterom, A T
Publicado em 2003

Isolated hypoxic hepatic perfusion with tumor necrosis factor-alpha, melphalan, and mitomycin C using balloon catheter techniques: a pharmacokinetic study in pigs.

Por van Ijken, M G, de Bruijn, E A, de Boeck, G, ten Hagen, T L, van der Sijp, J R, Eggermont, A M
Publicado em 1998

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

Por de Wilt, J H W, ten Hagen, T L M, de Boeck, G, van Tiel, S T, de Bruijn, E A, Eggermont, A M M
Publicado em 2000

Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study.

Por Vermeulen, P. B., Verhoeven, D., Fierens, H., Hubens, G., Goovaerts, G., Van Marck, E., De Bruijn, E. A., Van Oosterom, A. T., Dirix, L. Y.
Publicado em 1995

Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours.

Por Pronk, L. C., Schrijvers, D., Schellens, J. H., de Bruijn, E. A., Planting, A. S., Locci-Tonelli, D., Groult, V., Verweij, J., van Oosterom, A. T.
Publicado em 1998

Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment

Por Nijmeijer, S. W. R., de Bruijn, E., Verhagen, R., Forbes, P. A., Kamphuis, D. J., Happee, R., Tijssen, M. A. J., Koelman, J. H. T. M.
Publicado no Toxins (Basel) (2017)

Pharmacokinetics and bioavailability of oral 5′-deoxy-5-fluorouridine in cancer patients

Por Van Der Heyden, S A M, Highley, M S, De Bruijn, E A, Tjaden, U R, Reeuwijk, H J E M, Van Slooten, H, Van Oosterom, A T, Maes, R A A
Publicado em 1999

Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-α-based isolated hepatic perfusion

Por van Etten, B, de Vries, M R, van IJken, M G A, Lans, T E, Guetens, G, Ambagtsheer, G, van Tiel, S T, de Boeck, G, de Bruijn, E A, Eggermont, A M M, ten Hagen, T L M
Publicado em 2003